NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $181,608 | -2.6% | 25,084 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $186,374 | +7.2% | 25,084 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $173,832 | -32.6% | 25,084 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $257,864 | -73.2% | 25,084 | -52.6% | 0.00% | -76.9% |
| Q3 2022 | $963,000 | +19.8% | 52,907 | +238.3% | 0.01% | +18.2% |
| Q2 2022 | $804,000 | +3.5% | 15,638 | +48.2% | 0.01% | +22.2% |
| Q1 2022 | $777,000 | -56.3% | 10,551 | -15.2% | 0.01% | -57.1% |
| Q4 2021 | $1,780,000 | +73.7% | 12,438 | +151.6% | 0.02% | +425.0% |
| Q3 2021 | $1,025,000 | +101.0% | 4,944 | -94.3% | 0.00% | -55.6% |
| Q2 2019 | $510,000 | – | 86,956 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |